Cullinan Therapeutics, Inc. (CGEM)
NASDAQ · Healthcare
Cullinan Therapeutics, Inc. Operating Income 2020–2022
Cullinan Therapeutics, Inc. annual/quarterly operating income history and growth rate from 2020 to 2022. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Cullinan Therapeutics, Inc. operating income for the quarter ending September 30, 2022 was -29.8 M, a 61.99% increase year-over-year.
- Cullinan Therapeutics, Inc. operating income for the twelve months ending September 30, 2022 was 158.9 M.
- Cullinan Therapeutics, Inc. annual operating income for 2022 was 144.6 M, a 312.86% decrease from 2021.
- Cullinan Therapeutics, Inc. annual operating income for 2021 was -68.0 M, a 12.63% increase from 2020.
- Cullinan Therapeutics, Inc. annual operating income for 2020 was -60.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cullinan Therapeutics, Inc. Operating Income — FAQ
Cullinan Therapeutics, Inc. (CGEM) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Cullinan Therapeutics, Inc.'s operating income?
Cullinan Therapeutics, Inc. (CGEM) reported operating income of $145M for fiscal 2022.
Where can I see CGEM's operating income history?
The chart and table above show Cullinan Therapeutics, Inc.'s operating income by year and by quarter, including the growth rate.